Overnight, Nebius sent notices to its customers regarding a price increase as follows: The price for on-demand (PAYG) capacity will increase by an average 29%, and the price for preemptible (PVM) capacity will increase by 51%. The hike does not apply to existing customers. NBIS Reportedly Sees Record Demand “This update reflects continued strong demand…

To access this post, you must subscribe.

Read More

I made some changes in the High Growth portfolio this morning. I sold half of the Datadog position after its recent run. I think the shares are likely to consolidate after a 66% run in the past month. I decided to redeploy the funds to other positions that I believe have a grade potential for…

To access this post, you must subscribe.

Read More

The High Growth portfolio added to its minimal position in TempusAI shares. 500 shares were added at a price of $42.79 which cost $21, 405. We now have 750 shares of Tempus which has a weight of 1.38% in the high growth portfolio. We may add to the position to get the weight to a reasonable level.…

To access this post, you must subscribe.

Read More

Evgeny Gromov/iStock via Getty Images A healthcare technology company that uses AI as the basis for its solutions! Tempus Ai is probably not the best known company in the AI space at this stage of its evolution although it was named by Time Magazine as one of the 10 most influential software companies in a recent article.…

To access this post, you must subscribe.

Read More

Snowflake is set to report its earnings for the quarter ended April 30 later this month. While it has bounced some in the last month, it is still down more than 30% since the start of the year. The shares have been weak today, and we added to our position. Anecdotal checks suggest that usage…

To access this post, you must subscribe.

Read More

Nebius reported a particularly strong quarter earlier today-one of solid execution on all major fronts. While it reaffirmed it 2026 targets for revenue, ending ARR and margins, there were some metrics, particularly that of year-end capacity in terms of power (the company is now forecasting 4 GW up from 3 GW of contracted power at…

To access this post, you must subscribe.

Read More

Lots of earnings to look at and many to admire. This is turning out to be a quarter for most enterprise software companies in which growth rates and margins were both rising and guidance was better than had been anticipated. 1) Pagaya I think the best way to describe the results and the guidance of this…

To access this post, you must subscribe.

Read More

Portfolio Sale

We sold 250 shares of Dell, reducing the position in the income/Stability portfolio to 250 shares. The shares have had a huge run based on their positioning in the AI PC space. The shares have more than doubled since the start of the year and even after today’s drawdown, they are still up by more…

To access this post, you must subscribe.

Read More

After reviewing the earnings release, updating the model and reviewing the conference call transcript, I felt impelled to add to the Unity position. The Vector initiative is working out. The company is launching a further enhancement of significance to the platform in June. At that point, it will start to use the data from its…

To access this post, you must subscribe.

Read More

We added to 3 positions in the high growth portfolio and added a new company as well. These positions essentially replaced the sale we made yesterday of Nebius which raised about $78k. The purchases were as follows: 1) 250 shares of Tempus AI @ $50.39-purchase cost of $12,605 and weight of 0.55%. The Tempus purchase is obviously…

To access this post, you must subscribe.

Read More